Generative AI could offer the pharma industry a once-in-a-century opportunity—but only if they learn to scale it and address the industry’s unique challenges.
Generative AI can change real estate, but the industry must change to reap the benefits How generative AI could revitalize profitability for telcos Generative AI in the pharmaceutical industry: Moving from hype to reality Generative AI in finance: Finding the way to faster, deeper insights Ho...
From pharma R&D to the point-of-care, learn how generative AI can accelerate health innovations and improve patient outcomes.
Facing the future of generative AI, Guo Wei, chairman and CEO of Digital China, said in his speech, Digital China will also make a firm deployment in generative AI. In the future, enterprises will enter the era with the integration of cloud native, digital native, AI native technologies. I...
generative AI can provide tools and capabilities to individuals and organizations who may not have had access to them before, leveling the playing field and spurring a wave of grassroots innovation. This transformative impact highlights the far-reaching significance of generative AI in the modern world...
Gartner sees generative AI becoming a general-purpose technology with an impact similar to that of the steam engine, electricity and the internet. The hype will subside as the reality of implementation sets in, but the impact of generative AI will grow as people and enterprises discover more inn...
Post-market surveillance involves the analysis of high volumes of data and communications with large patient populations. Generative AI promises to transform efficiency in both areas.
NVIDIA today launched more than two dozen new microservices that allow healthcare enterprises worldwide to take advantage of the latest advances in generative AI from anywhere and on any cloud.
“Tokyo-1 is designed to address some of the barriers to implementing data-driven, AI-accelerated drug discovery in Japan,” said Hiroki Makiguchi, product engineering manager in the science and technology division at Xeureka. “This initiative will uplevel the Japanese pharmaceutical industry with ...
Generative AI (gen AI) is poised to transform nearly every aspect of the life sciences (LS) industry. The McKinsey Global Institute estimates that gen AI could generate $60 billion to $110 billion annually in economic value for pharmaceutical and medtech companies, with $18 bi...